Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Leiden
Clinical trial register · Netherlands

Clinical Trials in Leiden, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3175 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:17 UTC
3175
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1243 Rotterdam 855 Groningen 601 Nijmegen 565 Utrecht 545

Trials with a site in Leiden

386 of 3175 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Rotterdam, Amsterdam, Heerlen, Leiden, Nieuwegein
2026-12-16
Not yet open
Leiden University Medical Center
Observational
100
Leiden, Leidschendam, The Hague
2026-12
Recruiting
In-situ vs Ex-situ Liver Preservation
NCT07899853Liver Disease (Alcoholic or Not), Transplantation
Leiden University Medical Center
Not applicable
752
Groningen, Leiden, Rotterdam
2026-11-04
Not yet open
AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery
NCT07883551Ovarian Cancer, Ovarian Tumor, Borderline Ovarian Tumor
Catharina Ziekenhuis Eindhoven
Observational
1,300
Amsterdam, Breda, Eindhoven, Leiden, Maastricht
2026-11
Not yet open
The Netherlands Cancer Institute
Phase 2
30
Amsterdam, Leiden
2026-11
Not yet open
Eli Lilly and Company
Phase 2
330
's-Hertogenbosch, Amsterdam, Groningen, Leiden, Zwolle
2026-11
Not yet open
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
NCT07873931Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies
Bristol-Myers Squibb
Phase 1
60
Amsterdam, Leiden
2026-10-30
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
530
Groningen, Leiden, Nijmegen, Utrecht
2026-10-07
Not yet open
Nyika D. Kruyt
Not applicable
518
Leiden
2026-10-01
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
NCT07587242Muscular Dystrophies, Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy), Muscular Disorders, Atrophic, Muscular Disease
Avidity Biosciences, Inc.
Phase 3
70
Leiden
2026-09-01
Not yet open
The Netherlands Cancer Institute
Phase 2
56
Amsterdam, Leiden, Utrecht
2026-09-01
Recruiting
Leiden University Medical Center
Observational
30
Leiden
2026-09
Recruiting
Radboud University Medical Center
Not applicable
170
Amsterdam, Leiden, Nijmegen, Rotterdam
2026-08-10
Recruiting
Patient-Ventilator Asynchrony: Occurence and Clinical Impact in Usual Care
NCT07624786Mechanical Ventilation, Patient-Ventilator Asynchrony
Erasmus Medical Center
Observational
110
Eindhoven, Leiden, Rotterdam
2026-07-21
Recruiting
argenx
Phase 2
40
Leiden
2026-07-10
Recruiting
LEOPARD Prospective Validation Cohort 1
NCT06723275Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
630
Leiden
2026-07-07
Recruiting
Prilenia
Phase 3
400
Leiden
2026-07-01
Recruiting
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
NCT07636148Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor
Mark C Burgmans, MD PhD
Observational
2,000
Leiden
2026-07-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Nijmegen, Hengelo, Leiden, Groningen
2026-06-18
Active, closed
Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9
NCT07678775Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
ML Bio Solutions, Inc.
Phase 3
107
Leiden
2026-06-05
Not yet open
Venous Resection in Patients Undergoing Pancreatic Surgery
NCT07621029IPMN, Pancreatic, Pancreatic Cancer, Resected, Pancreatic Cancer Borderline, Chronic Pancreatitis
Sahlgrenska University Hospital
Observational
1,000
Leiden
2026-06-01
Recruiting
Leiden University Medical Center
Observational
233
Leiden
2026-06-01
Recruiting
Bleeding Disorder of Unknown Cause in the Netherlands
NCT07454161Hemorrhagic Disorders, Bleeding Disorder of Unknown Cause
Maastricht University Medical Center
Observational
500
Nijmegen, Maastricht, Veldhoven, Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2026-06-01
Recruiting
Novartis Pharmaceuticals
Phase 1
194
Leiden
2026-05-28
Recruiting
SAR447971 First-in-human Study
NCT07629336Hidradenitis, Healthy Volunteers
Sanofi
Phase 1
122
Leiden
2026-05-26
Recruiting
Ipsen
Phase 3
350
Nijmegen, Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2026-05-14
Recruiting
University Medical Center Groningen
Phase 4
261
Amsterdam, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam
2026-05-11
Recruiting
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890End-stage Liver Disease (ESLD), Acute Liver Failure, Liver Cirrhosis, Liver Transplantation
University Medical Center Groningen
Observational
10,000
Groningen, Leiden
2026-04-21
Recruiting
Tessera Therapeutics, Inc.
Phase 1/2
72
Leiden
2026-04-21
Recruiting
Low-Field MRI in Stroke Code Patients
NCT07702968Acute Stroke, MRI Imaging
Leiden University Medical Center
Observational
80
Leiden
2026-04-20
By invitation
BioMarin Pharmaceutical
Phase 2
18
Leiden
2026-04-20
Recruiting
Salvia BioElectronics
Not applicable
10
Leiden
2026-04-13
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Maastricht, Leiden
2026-03-24
Recruiting
AIRNA Corporation
Phase 1
54
Leiden
2026-03-17
Recruiting
SymBio Pharmaceuticals
Phase 3
180
Leiden, Utrecht
2026-03-17
Recruiting
Leiden University Medical Center
Not applicable
60
Leiden, Rotterdam
2026-03-13
Recruiting
Almirall, S.A.
Phase 1
93
Leiden
2026-02-17
Recruiting
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
NCT07161869Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma, Perihilar Cholangiocarcinoma
Erasmus Medical Center
Observational
250
Rotterdam, Amsterdam, Groningen, Leiden, Maastricht, Utrecht
2026-02-05
Recruiting
Genmab
Phase 2
240
Amsterdam, Leiden, Nijmegen
2026-01-30
Recruiting
dr. Tom van der Hulle
Phase 2
34
Leiden
2026-01-26
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Harderwijk, Nijmegen, Leiden
2025-12-22
Recruiting
UNICANCER
Phase 3
3,902
Arnhem, Hilversum, Hoofddorp, Leeuwarden, Leiden, Venlo
2025-12-18
Recruiting
University of Cologne
Phase 3
420
Groningen, Leiden, Rotterdam
2025-12-16
Recruiting
Angitia Incorporated Limited
Phase 2
80
Leiden, Rotterdam, Zwolle
2025-12-12
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.
Phase 3
150
Leiden, Nijmegen
2025-12-11
Recruiting
Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas
NCT07071727Sarcoma of Soft Tissue, Sarcoma, Sarcoma, Soft Tissue
The Netherlands Cancer Institute
Not applicable
150
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
2025-12-11
Recruiting
Regeneron Pharmaceuticals
Phase 1
46
Leiden
2025-12-05
Recruiting
GlaxoSmithKline
Phase 3
450
Amsterdam, Leiden, Nijmegen, Rotterdam
2025-12-03
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca
Phase 1/2
152
Amsterdam, Groningen, Leiden
2025-11-24
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Arnhem, Sittard-Geleen, 's-Hertogenbosch, Amsterdam, Leiden
2025-11-11
Recruiting
Universiteit Leiden
Not applicable
126
Leiden
2025-11-01
Recruiting
Vertero Therapeutics
Phase 1
84
Leiden
2025-10-30
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Amsterdam-Zuidoost, Leiden, Nijmegen, Rotterdam
2025-10-06
Recruiting
Leiden University Medical Center
Not applicable
360
Leiden
2025-10-06
Recruiting
Optimized Expansion of the Implanted Transcatheter Aortic Valve
NCT07042529Aortic Stenosis Disease, Valvular Heart Disease
Ole De Backer
Not applicable
1,010
Amsterdam, Groningen, Leiden, Nieuwegein
2025-10-05
Recruiting
Vertero Therapeutics
Observational
200
Leiden
2025-09-25
Recruiting
Erasmus Medical Center
Not applicable
241
Eindhoven, Leiden, Rotterdam
2025-09-23
Recruiting
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Phase 4
50
Amsterdam, Leiden
2025-09-17
Recruiting
Erasmus Medical Center
Phase 2
216
Eindhoven, Leeuwarden, Tilburg, Amsterdam, Rotterdam, Almelo, Apeldoorn, Leiden
2025-09-12
Recruiting
Entrada Therapeutics, Inc.
Phase 1/2
24
Leiden, Nijmegen
2025-08-30
Recruiting
Leiden University Medical Center
Observational
98
Leiden
2025-08-14
Recruiting
Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial
NCT07281508Cisplatin-related Hearing Loss
The Netherlands Cancer Institute
Phase 3
100
Amsterdam, Leiden, Rotterdam, Utrecht, Nijmegen
2025-08-14
Recruiting
Sanofi
Phase 3
723
Amersfoort, Leiden, Rotterdam
2025-08-06
Recruiting
St. Antonius Hospital
Not applicable
345
Leiden
2025-07-31
Recruiting
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
NCT07021495Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO), Atopic Dermatitis (AD)
Leiden University Medical Center
Observational
840
Nijmegen, Maastricht, Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2025-07-29
Recruiting
Managing Pasireotide-associated Hyperglycaemia in Acromegaly With Ketogenic Diet
NCT07866846Acromegaly Due to Pituitary Adenoma, Hyperglycemia, Ketogenic Diet, Standard Care Control
Leiden University Medical Center
Not applicable
30
Leiden
2025-07-29
Recruiting
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
NCT07047703Axial Spondyloarthritis (AxSpA)
Grey Wolf Therapeutics
Phase 1/2
140
Amsterdam, Leiden
2025-07-28
Recruiting
Leiden University Medical Center
Observational
600
Leiden
2025-07-22
Recruiting
Takeda
Phase 3
347
Amsterdam, Leiden, Nieuwegein, Nijmegen, Utrecht
2025-07-15
Recruiting
Surface Electrical Myography, Oxygen Consumption, Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit
NCT07109570Critical Illness, Intensive Care Units (ICUs), Weaning Failure, Mechanical Ventilation
Leiden University Medical Center
Observational
60
Leiden
2025-07-08
Recruiting
[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer
NCT07018661Locally Advanced Gastric Adenocarcinoma, STOMACH NEOPLASM, Gastric Cancer, PET-CT
Leiden University Medical Center
Phase 2/3
250
Almelo, Amsterdam, Arnhem, Eindhoven, Geleen, Groningen, Leiden, Rotterdam
2025-07-03
Recruiting
Leiden University Medical Center
Not applicable
50
Leiden
2025-07-01
Recruiting
The Netherlands Cancer Institute
Phase 3
408
Amsterdam, Leiden, Maastricht, The Hague, Utrecht
2025-06-19
Active, closed
Novartis Pharmaceuticals
Phase 1
57
Leiden
2025-06-12
Recruiting
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
NCT07038200Facioscapulohumeral Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy, FSHD1
Avidity Biosciences, Inc.
Phase 3
200
Leiden, Nijmegen
2025-06-10
Recruiting
Calico Life Sciences LLC
Phase 2
240
Groningen, Dordrecht, Leiden, Rotterdam
2025-06-09
Active, closed
Incyte Corporation
Phase 3
9
Amsterdam, Groningen, Leiden, Maastricht, Rotterdam, Utrecht
2025-06-04
Recruiting
Roxanne Gal
Phase 2
246
Amersfoort, Gouda, Leiden, Nijmegen
2025-06-02
Recruiting
Smart Measurement of Circulating Tumor DNA
NCT06989814Colorectal Neoplasms, Colorectal Neoplasms Malignant, Colorectal Neoplasms, Hereditary Nonpolyposis, Hereditary Nonpolyposis Colon Cancer
Erasmus Medical Center
Not applicable
50
Leiden, Rotterdam
2025-05-16
Recruiting
AstraZeneca
Phase 1
72
Amsterdam, Leiden
2025-05-01
Recruiting
Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer
NCT07146295Breast Cancer, Sentinel Lymph Node Biopsy (SLNB), Sentinel Lymph Node Detection, Sentinel Lymph Node
Isabelle Henskens
Not applicable
1,760
Alkmaar, Hengelo, Hoofddorp, Hoorn, Leiden, Nijmegen, Utrecht
2025-04-18
Recruiting
Neurocrine Biosciences
Phase 3
850
Amsterdam, Groningen, Leiden
2025-04-16
Recruiting
LSD to Improve Cluster Headache Impact Trial
NCT05477459Chronic Cluster Headache
Radboud University Medical Center
Phase 2
65
Leiden, Nijmegen
2025-04-16
Recruiting
University of Twente
Not applicable
150
Amsterdam, Arnhem, Breda, Eindhoven, Enschede, Groningen, Leiden, Nieuwegein
2025-04-10
Recruiting
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Primary Liver Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Maastricht University
Not applicable
358
Maastricht, Amsterdam, Eindhoven, Groningen, Leiden
2025-04-01
Recruiting
Leiden University Medical Center
Not applicable
300
Leiden
2025-04
By invitation
Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy
NCT06421532Cerebral Amyloid Angiopathy
DrugXywav
Leiden University Medical Center
Phase 2
60
Leiden
2025-03-27
Recruiting
Leiden University
Not applicable
936
Leiden
2025-03-27
Recruiting
Capturing Key MG-symptoms Using Smartphone Recordings.
NCT06743490Myasthenia Gravis, Fatigue
Leiden University Medical Center
Observational
225
Leiden
2025-03-18
Recruiting
The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
NCT06874426Meningioma, Pituitary Disease, Pituitary Adenoma, Craniopharyngioma
Universitaire Ziekenhuizen KU Leuven
Observational
154
Leiden
2025-03-18
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Amsterdam, Arnhem, Breda, Dordrecht, Eindhoven, Groningen, Leiden, Maastricht
2025-03-14
Recruiting
Pfizer
Phase 3
723
Nijmegen, Zwolle, Leiden
2025-03-11
Recruiting
AstraZeneca
Phase 3
5,000
Amersfoort, Amsterdam, Dordrecht, Groningen, Hilversum, Leiden, Maastricht, Nieuwegein
2025-03-03
Recruiting
AstraZeneca
Phase 3
840
Amsterdam, Arnhem, Leiden
2025-03-01
Not yet open
Clostridioides Difficile Controlled Human Infection Model
NCT06702345C. Difficile, C. Difficile Infection, Controlled Human Infection
Leiden University Medical Center
Not applicable
60
Leiden
2025-03-01
Not yet open
Re-ablation of Persistent Atrial Fibrillation
NCT06845085Atrial Fibrillation, Persistent
Aarhus University Hospital
Not applicable
180
Leiden
2025-03
Recruiting
Janssen Research & Development, LLC
Phase 3
50
Leiden
2025-02-10
Active, closed
Genmab
Phase 3
584
Amsterdam, Enschede, Leiden, Maastricht, Rotterdam
2025-02-07
Recruiting
LEOPARD Training and Validation Data Collection Study
NCT06675604Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
4,500
Leiden, Rotterdam
2025-02-04
Recruiting
Leiden University Medical Center
Not applicable
111
Leiden
2025-02
Recruiting
Universiteit Leiden
Not applicable
30
Leiden
2025-01-31
Recruiting
Deep Phenotyping of CIndU
NCT07359430Skin Diseases, Angio-Oedema and/or Urticaria
Centre for Human Drug Research, Netherlands
Observational
40
Leiden, Rotterdam, Utrecht
2025-01-21
Recruiting
Erasmus Medical Center
Not applicable
120
Amsterdam, Leiden, Rotterdam, Utrecht
2025-01-15
Recruiting
Italfarmaco
Phase 2
18
Leiden
2025-01-02
Not yet open
Huntington's Disease and Pain
NCT06693466Huntington Disease, Pain
Leiden University Medical Center
Observational
20
Leiden
2025-01
Recruiting
Prevention of PostAmputation Pain With Targeted Muscle Reinnervation
NCT06719245Amputation, Surgical, Phantom Limb Pain, Neuroma Amputation, Surgery
Leiden University Medical Center
Not applicable
203
Amsterdam, Zwolle, Leiden, Leiderdorp, Rotterdam, The Hague, Utrecht
2024-12-31
Recruiting
Calibration of Esophageal Balloon Catheter in Spontaneous and Mandatory Mechanical Ventilation
NCT06584604Intensive Care Unit, Mechanical Ventilation, Critical Illness
Leiden University Medical Center
Observational
40
Leiden
2024-12-29
Recruiting
Fundación para la Investigación Biosanitaria del Principado de Asturias
Not applicable
250
Amsterdam, Breda, Eindhoven, Leiden, Maastricht, Nieuwegein, Rotterdam, Zwolle
2024-12-24
Recruiting
Fundación EPIC
Not applicable
128
Leiden
2024-12-17
Recruiting
Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion
NCT05782543Kidney Transplant; Complications
University Medical Center Groningen
Not applicable
240
Groningen, Leiden, Rotterdam
2024-12-15
Active, closed
Leiden University Medical Center
Not applicable
60
Leiden
2024-12-04
Active, closed
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
94
Amsterdam, Leiden
2024-11-28
Recruiting
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
NCT06560164Transfusion, Red Blood Cell, Extracorporeal Membrane Oxygenation, Anemia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
526
Enschede, Nijmegen, Maastricht, Amsterdam, Groningen, Leiden, Rotterdam, Nieuwegein
2024-11-26
Active, closed
Genmab
Phase 3
191
Amsterdam, Harderwijk, Heerlen, Leiden, Nijmegen, Rotterdam, Utrecht, Zwolle
2024-11-25
Recruiting
Zealand Pharma
Phase 1
124
Leiden
2024-11-12
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
290
Leiden, Rotterdam
2024-11-11
Active, closed
argenx
Phase 2
87
Leiden
2024-11-11
Active, closed
Santhera Pharmaceuticals
Phase 4
80
Leiden, Nijmegen
2024-11-10
Recruiting
InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
NCT05961059Shigellosis, Bacillary Dysentery
Leiden University Medical Center
Phase 1
85
Leiden
2024-10-10
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Leiden
2024-10-09
Active, closed
Novartis Pharmaceuticals
Phase 1
54
Leiden
2024-10-08
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Harderwijk, Heerlen, 's-Hertogenbosch, Zwolle, Leiden, The Hague, Arnhem, Groningen
2024-10-07
Recruiting
Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
NCT06883448Pulmonary Fibrosis, Interstitial Lung Disease (ILD)
Erasmus Medical Center
Not applicable
220
Amsterdam, Arnhem, Breda, Eindhoven, Heerlen, Leeuwarden, Leiden, Nieuwegein
2024-10-02
Active, closed
Boehringer Ingelheim
Phase 3
1,666
HEERLENHeerlen, Leiden, Nieuwegein, Rotterdam
2024-09-26
Active, closed
argenx
Phase 3
141
Leiden
2024-09-18
Recruiting
Left Bundle Branch Area Pacing or Biventricular Pacing in AF and Left Ventricular Dysfunction
NCT06620705Heart Failure, Block, Heart, Pacing-Induced Cardiomyopathy
srdpiers
Not applicable
34
Leiden
2024-09-10
Recruiting
Lakefront Biotherapeutics NV
Phase 3
546
Amsterdam, Leiden, Rotterdam
2024-09-09
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Groningen, Leiden, Utrecht
2024-09-04
Recruiting
Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
NCT05851534Prehabilitation, Pancreas Cancer, Surgery, Postoperative Complications
Maastricht University Medical Center
Not applicable
2,575
's-Hertogenbosch, Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leeuwarden, Leiden
2024-09-02
Recruiting
CRS Questionnaire Validation Project
NCT06970977Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
The European Forum for Research and Education in Allergy and Airway Diseases
Observational
1,000
Amsterdam, Leiden
2024-09-01
Recruiting
MB-dNPM1-TCR.1 in Relapsed/Refractory AML
NCT06424340Leukemia, Myeloid, Acute
Miltenyi Biomedicine GmbH
Phase 1/2
29
Leiden
2024-08-01
Recruiting
The OPTIMISE Study
NCT05716945Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure
Maastricht University Medical Center
Phase 4
342
Apeldoorn, Nijmegen, Maastricht, Amsterdam, Deventer, Groningen, Leiden, Utrecht
2024-07-29
Recruiting
Erasmus Medical Center
Not applicable
200
Breda, Capelle aan den IJssel, Leiden, Rotterdam
2024-07-18
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Servier Bio-Innovation LLC
Phase 3
156
Groningen, Leiden, Nijmegen
2024-07-09
Recruiting
argenx
Phase 2/3
12
Leiden
2024-06-28
Recruiting
Curadel Surgical Innovations, Inc.
Phase 2/3
336
Groningen, Leiden, Rotterdam, Zwolle
2024-06-28
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
60
Leiden
2024-06-19
Recruiting
Beam Therapeutics Inc.
Phase 1/2
192
Leiden
2024-06-19
Recruiting
Outcomes in Moderate Mixed Aortic Valve Disease
NCT06789211Mixed Aortic Valve Disease
Leiden University Medical Center
Observational
1,900
Leiden
2024-06-06
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Leiden, Utrecht
2024-05-20
Active, closed
Alnylam Pharmaceuticals
Phase 2
210
Amsterdam, Leiden, Nijmegen
2024-05-17
Recruiting
NMD Pharma A/S
Phase 2
84
Leiden
2024-05-16
Recruiting
Maastricht University
Not applicable
35
Maastricht, Leiden
2024-05-03
Active, closed
Erasca, Inc.
Phase 3
78
Amsterdam, Leiden, Nijmegen
2024-04-29
Active, closed
argenx
Phase 3
119
Leiden, Utrecht
2024-04-16
Recruiting
Learn to Dare! Leiden
NCT06609824Childhood Anxiety, Shyness
Leiden University
Not applicable
48
Leiden
2024-04-02
Not yet open
Midline Restoration After HYbriD Hernia RepAir Surgery (HYDRA)
NCT06286124Incisional Hernia of Midline of Abdomen
Erasmus Medical Center
Observational
52
Leiden
2024-04
Recruiting
Leiden University Medical Center
Not applicable
400
Groningen, Leiden, Maastricht, Sittard
2024-03-25
Recruiting
Leiden University Medical Center
Phase 2
20
Leiden
2024-03-18
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Leiden, Rotterdam, Tilburg
2024-03-15
Recruiting
The Bipolar Lithium Imaging Scan Study.
NCT06134349Bipolar Disorder I or II
Leiden University Medical Center
Observational
80
Leiden
2024-03-13
Recruiting
The NEU-STIM Trial
NCT05942924Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Leiden, Rotterdam
2024-03-11
Recruiting
The Netherlands Cancer Institute
Phase 1/2
96
Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2024-03-08
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
Daiichi Sankyo
Phase 2
740
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
2024-02-26
Recruiting
Aleksander Krag
Phase 3
240
Leiden, Leiderdorp
2024-02-26
Recruiting
Italfarmaco
Phase 3
138
Leiden, Nijmegen
2024-02-19
Active, closed
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
NCT06237920Urologic Neoplasms, Urogenital Neoplasms, Neoplasms by Site, Neoplasms
The Netherlands Cancer Institute
Phase 2
90
Arnhem, Nijmegen, Amsterdam, Hoofddorp, Zwolle, Leiden, Rotterdam, Utrecht
2024-02-19
Recruiting
BioClock: Bright Light Therapy for Depressive Disorders
NCT05958940Depression, Unipolar, Depression, Bipolar
Universiteit Leiden
Not applicable
231
Eindhoven, Leiden
2024-02-08
Recruiting
Stroke Triage Optimization by Ambulance Paramedics in the Pre-hospital Setting
NCT06332989Stroke, Acute, Pre-hospital Triage, Stroke Treatment, Stroke Code
Leiden University Medical Center
Observational
3,000
Leiden
2024-02-01
Recruiting
Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages
NCT05725512Recurrent Miscarriage, Recurrent Pregnancy Loss, Habitual Abortion, Miscarriage
Leiden University Medical Center
Phase 4
490
Leiden
2024-01-29
Recruiting
Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures
NCT07380217High-risk PCI, Coronary Artery Disease Risk High
Amsterdam UMC, location VUmc
Not applicable
98
Amsterdam, Geleen, Groningen, Leiden, Maastricht, Nijmegen, The Hague, Utrecht
2024-01-25
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
Revolution Medicines, Inc.
Phase 1/2
616
Amsterdam, Groningen, Leiden, Utrecht
2024-01-18
Active, closed
BioMarin Pharmaceutical
Phase 1/2
18
Leiden
2024-01-03
Recruiting
Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC
NCT05905315Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva
The Netherlands Cancer Institute
Phase 2
98
Amsterdam, Leiden
2024-01-01
Recruiting
Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors
NCT06179602Liver Cancer, Liver Metastases, Liver Metastasis Colon Cancer, Hepatocellular Carcinoma
Leiden University Medical Center
Observational
1,500
Leiden
2024-01-01
Recruiting
Daiichi Sankyo
Phase 3
250
Amsterdam, Breda, Leeuwarden, Leiden, Maastricht, The Hague, Tilburg, Uden
2023-12-30
Recruiting
Eli Lilly and Company
Phase 3
1,264
's-Hertogenbosch, Enschede, Harderwijk, Hilversum, Leeuwarden, Leiden, Rotterdam, Tilburg
2023-12-21
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Leiden
2023-12-20
Recruiting
Improving CRT Outcome With Non-Invasive Cardiac Mapping
NCT05564793Heart Failure With Reduced Ejection Fraction
EP Solutions SA
Not applicable
330
Amsterdam, Groningen, Leiden, Maastricht, Utrecht
2023-12-20
Recruiting
The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
NCT06685562Breast Cancer Patients, Melanoma Cancer, Prostate Cancer, Supportive Care in Cancer
Leiden University Medical Center
Observational
500
Leiden
2023-12-20
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
54
Groningen, Leiden
2023-12-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Nijmegen, Amsterdam, Leiden
2023-12-06
Active, closed
Aura Biosciences
Phase 3
108
Leiden, Rotterdam
2023-12-06
Recruiting
Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.
NCT05333523Laryngeal Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Radboud University Medical Center
Phase 3
242
Amsterdam, Arnhem, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam
2023-12-06
Recruiting
Leiden University Medical Center
Not applicable
50
Leiden
2023-12-01
Recruiting
Leiden University Medical Center
Observational
50
Leiden
2023-11-25
By invitation
Edgewise Therapeutics, Inc.
Phase 2
260
Leiden
2023-11-02
Recruiting
EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial
NCT06767332Familial Melanoma, Fear of Cancer Recurrence, Eye Movement Desensitization and Reprocessing, Psychological Intervention
Leiden University Medical Center
Not applicable
30
Leiden
2023-11-01
Recruiting
Leiden University Medical Center
Observational
100
Leiden
2023-11-01
Recruiting
RCT: the Effectiveness of LifeHack in Improving Mental Wellbeing in University Students.
NCT06423417Internet-based Intervention, Waiting List Control Group, Depression, Anxiety
Universiteit Leiden
Not applicable
217
Amsterdam, Leiden
2023-11-01
Active, closed
IDEAYA Biosciences
Phase 2/3
420
Leiden
2023-10-31
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Leiden, Rotterdam, Nieuwegein, Amsterdam, Heerlen
2023-10-25
Recruiting
Leiden University Medical Center
Phase 3
148
Leiden
2023-10-01
Not yet open
Unloading in Heart Failure Cardiogenic Shock
NCT05064202Cardiogenic Shock
Amsterdam UMC, location VUmc
Not applicable
456
Amsterdam, Groningen, Leiden, Utrecht
2023-10-01
Recruiting
Abbott Medical Devices
Observational
1,000
Amsterdam, Leiden, Utrecht
2023-09-29
Active, closed
Longevity Families of the Netherlands
NCT06374069Longevity, Familial Longevity, Extreme Longevity, Aging
Leiden University Medical Center
Observational
600
Leiden
2023-09-11
Active, closed
Leiden University Medical Center
Observational
120
Leiden
2023-09-04
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Amsterdam, Enschede, Groningen, Leiden, Nieuwegein, Rotterdam, The Hague
2023-09-01
Active, closed
Novartis Pharmaceuticals
Phase 2
144
Leiden
2023-08-25
Active, closed
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
NCT05987527Kidney Transplant Rejection, End Stage Renal Disease
Sangamo Therapeutics
Observational
11
Groningen, Leiden, Rotterdam
2023-08-15
Recruiting
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
NCT05958121Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Immatics Biotechnologies GmbH
Phase 1/2
400
Amsterdam, Leiden, Groningen, Utrecht
2023-08-09
Active, closed
Pursuing the Triple Aim in Hotspotters: Identification and Integrated Care
NCT05878054Complex Patient, Multimorbidity, Psychosocial Problem, Chronic Disease
Leiden University Medical Center
Not applicable
41
Leiden
2023-08-02
Active, closed
Neuroinflammation in FTLD
NCT06870838Corticobasal Syndrome(CBS), Primary Progressive Aphasia(PPA), Progressive Supranuclear Palsy(PSP), Behavioral Variant Frontotemporal Dementia (bvFTD)
Leiden University Medical Center
Observational
110
Leiden, Rotterdam
2023-07-25
Recruiting
Stop Smoking in Spine Surgery
NCT06361459Smoking Cessation
Leiden University Medical Center
Not applicable
210
Leiden
2023-07-06
Active, closed
Hansa Biopharma AB
Phase 3
150
Leiden, Rotterdam
2023-07-03
Active, closed
IDEAYA Biosciences
Phase 2
160
Leiden
2023-07-03
Recruiting
International Cardiac Amyloidosis Registry
NCT06894290Cardiac Amyloidosis
Leiden University Medical Center
Observational
300
Leiden
2023-06-30
Recruiting
Dutch Registry of Pediatric Cardiac Arrest
NCT06938009Cardiac Arrest (CA), Pediatric ALL
Matthijs de Hoog
Observational
500
Nijmegen, Maastricht, Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2023-06-14
Recruiting
Natasha Appelman-Dijkstra
Phase 4
82
Leiden
2023-06-13
Active, closed
proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2
NCT05590143Acute Kidney Injury, Cardiac Surgery, Sodium-Glucose Transporter 2 Inhibitor
Amsterdam UMC
Phase 4
784
Amsterdam, Breda, Enschede, Leiden, Nieuwegein
2023-06-09
Recruiting
Erasmus Medical Center
Not applicable
430
Breda, Eindhoven, Amsterdam, Leiden, Rotterdam, The Hague, Nieuwegein, Utrecht
2023-06-08
Active, closed
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
NCT05778071Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases
Alexion Pharmaceuticals, Inc.
Phase 3
165
Leiden, Rotterdam
2023-06-07
By invitation
Angela HUTTNER
Observational
500
Leiden
2023-06-06
Not yet open
Metal-ions in Patients With the PEEK HD Coupling Mechanism of the Knee
NCT05893602Mutars, Modular Universal Tumor And Revision System, Metal-ions, Tumor Prosthesis
Leiden University Medical Center
Observational
30
Leiden
2023-06
Active, closed
ML Bio Solutions, Inc.
Phase 3
112
Leiden
2023-05-31
Active, closed
Amgen
Phase 3
509
Groningen, Leiden, Rotterdam, Utrecht
2023-05-31
Recruiting
University of Aarhus
Not applicable
554
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
2023-05-24
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1/2
7
Leiden
2023-05-16
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
238
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht, Veldhoven
2023-05-15
Active, closed
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)
NCT05804045Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath
Abbisko Therapeutics Co, Ltd
Phase 3
94
Leiden
2023-04-27
Recruiting
Effects Branch PA Stenting d-TGA, ToF and TA
NCT05809310Transposition of Great Vessels, Tetralogy of Fallot, Truncus Arteriosus, Pulmonary Artery Stenosis Supravalvular Congenital
UMC Utrecht
Not applicable
56
Amsterdam, Leiden, Rotterdam, Utrecht
2023-04-18
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Leiden, Rotterdam, Maastricht
2023-04-17
Recruiting
Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
NCT06172010Prosthetic-joint Infection, Infection Hip, Infection; Knee, Joint
Leiden University Medical Center
Phase 4
316
Leiden, Amsterdam, Groningen, Hoofddorp, Leeuwarden, Leiderdorp, Nijmegen, Rotterdam
2023-04-01
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
1,650
Amsterdam, Leiden, Rotterdam
2023-03-21
Recruiting
The (Cost-)Effectiveness of Surgical Excision of Colorectal Endometriosis Compared to ART Treatment Trajectory
NCT05677269Endometriosis, Rectum, Endometriosis of Colon, Subfertility, Female
Leiden University Medical Center
Observational
339
Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, The Hague
2023-02-17
Recruiting
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
NCT05952583Twin; Pregnancy, Affecting Fetus or Newborn, Fetal Growth Retardation, Twin Monochorionic Diamniotic Placenta, Twin Diseases
Leiden University Medical Center
Observational
274
Leiden
2023-02-17
Recruiting
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
NCT05822908Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease
Vico Therapeutics B. V.
Phase 1/2
68
Leiden, Nijmegen
2023-02-14
Active, closed
COMPASS Pathways
Phase 3
572
Groningen, Leiden, Utrecht
2023-02-14
Active, closed
Kite, A Gilead Company
Phase 3
300
Amsterdam, Groningen, Leiden, Maastricht, Utrecht
2023-02-10
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Leiden, Utrecht
2023-02-02
Recruiting
WHIte MAtter Hyperintensity Shape and Glymphatics
NCT06010511Cerebral Small Vessel Diseases, Dementia, Mixed, Dementia, Vascular, Mild Cognitive Impairment
Leiden University Medical Center
Observational
50
Leiden
2023-01-18
Active, closed
Algernon Pharmaceuticals
Phase 1
60
Leiden
2023-01-13
Active, closed
Daiichi Sankyo
Phase 3
1,233
's-Hertogenbosch, Breda, Leiden
2023-01-11
Recruiting
Leiden University Medical Center
Phase 2
20
Leiden
2023-01-01
Recruiting
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
NCT06932081Adult Congenital Heart Disease, Congenital Heart Disease, Systemic Right Ventricle, Transposition of the Great Arteries
Leiden University Medical Center
Observational
400
Leiden, Amsterdam, Utrecht
2023-01-01
Recruiting
Canadian Cancer Trials Group
Phase 2
393
Arnhem, Maastricht, Eindhoven, The Hague, Leiden, Rotterdam
2022-12-19
By invitation
Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation
NCT05628779Tricuspid Valve Regurgitation, Nonrheumatic, Cardiac Catheterization, Heart Failure, Right Sided, Valve Regurgitation, Tricuspid
St. Antonius Hospital
Not applicable
150
Amsterdam, Groningen, Leiden, Maastricht, Nieuwegein, Rotterdam
2022-12-12
Active, closed
Personalised Therapeutics @LUMC
NCT05508763Adverse Drug Reaction
Leiden University Medical Center
Observational
2,000
Leiden
2022-12-01
Recruiting
Leiden University Medical Center
Phase 2
168
Nijmegen, Hoofddorp, Zwolle, Gouda, Leiden, Amersfoort, Groningen
2022-11-10
Recruiting
Repeated GON Injections in CCH
NCT05324748Cluster Headache
Leiden University Medical Center
Phase 3
50
Leiden, Nijmegen
2022-11-07
Recruiting
Dutch Intracerebral Hemorrhage Surgery Trial
NCT05460793Intracerebral Hemorrhage, Minimally Invasive Surgical Procedures, Endoscopic Surgical Procedures
Radboud University Medical Center
Not applicable
600
Amsterdam, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, The Hague
2022-11-03
Active, closed
University Medical Center Groningen
Phase 2
340
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
2022-10-18
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Rotterdam, Amsterdam, Groningen, Leiden, Roosendaal
2022-10-04
Active, closed
Genmab
Phase 3
549
Nijmegen, Breda, Amsterdam, Hoorn, Enschede, Dordrecht, Leiden, Rotterdam
2022-09-20
By invitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Leiden
2022-09-01
Active, closed
Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy
NCT04711330Non Small Cell Lung Cancer Stage III, Immunotherapy
Leiden University Medical Center
Observational
126
Amsterdam, Leiden
2022-09-01
Active, closed
Erasmus Medical Center
Not applicable
228
Leiden, Rotterdam, The Hague
2022-09-01
Recruiting
Leiden University Medical Center
Observational
180
Leiden, Rotterdam
2022-08-16
Recruiting
Leiden University Medical Center
Not applicable
211
Leiden
2022-07-25
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Amsterdam, Dordrecht, Leiden, Maastricht, Rotterdam, Utrecht
2022-07-22
Recruiting
Leiden University Medical Center
Observational
10
Leiden
2022-07-21
Recruiting
Janssen Research & Development, LLC
Phase 2/3
12
Leiden
2022-07-20
Active, closed
GlaxoSmithKline
Phase 3
163
Groningen, Leiden
2022-07-14
Active, closed
Daiichi Sankyo
Phase 3
586
Amsterdam, Arnhem, Harderwijk, Leiden, Rotterdam, Utrecht
2022-07-08
Active, closed
Novartis Pharmaceuticals
Phase 1/2
66
Leiden
2022-07-04
Active, closed
Phase III Trial of Sirolimus in IBM
NCT04789070Inclusion Body Myositis
University of Kansas Medical Center
Phase 3
140
Leiden
2022-07-01
By invitation
Clinical Outcome After Total Pancreatectomy With Islet Autotransplantation
NCT05287737Islets of Langerhans Transplantation, Pancreatitis, Chronic, Diabetes Mellitus
Leiden University Medical Center
Observational
100
Leiden
2022-06-21
Recruiting
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
NCT05405270Cervical High Grade Squamous Intraepithelial Lesion, Cervical Intraepithelial Neoplasia Grade 2/3, CIN 2/3, Cervical Intraepithelial Neoplasia
Catharina Ziekenhuis Eindhoven
Observational
410
Breda, Dordrecht, Eindhoven, Hilversum, Leeuwarden, Leiden, Maastricht, Nijmegen
2022-06-01
Active, closed
IO Biotech
Phase 3
407
Amsterdam, Leiden, Maastricht, Rotterdam, Utrecht
2022-05-17
Active, closed
Pierre Fabre Medicament
Phase 3
815
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht, Zwolle
2022-05-02
Recruiting
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
NCT05406856Uterine Cervical Neoplasms, Locally Advanced Cervical Carcinoma
Leiden University Medical Center
Not applicable
30
Leiden, Rotterdam
2022-05-02
Active, closed
Verastem, Inc.
Phase 1/2
153
Leiden, Rotterdam
2022-04-12
Recruiting
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
NCT05525338Drug Monitoring, Carcinoma, Non-Small-Cell Lung, Lung Cancer, Anaplastic Lymphoma Kinase Gene Mutation
University Medical Center Groningen
Phase 4
196
Nijmegen, Maastricht, Amsterdam, Leiden, Rotterdam, Groningen
2022-03-23
Active, closed
Daiichi Sankyo
Phase 3
740
Arnhem, 's-Hertogenbosch, Amsterdam, Leiden
2022-03-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Nijmegen, Maastricht, Eindhoven, Amsterdam, Leiden, Rotterdam, Groningen, Utrecht
2022-02-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Nijmegen, Leiden, Rotterdam, Utrecht
2021-12-13
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Amsterdam, Arnhem, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, The Hague
2021-12-09
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Eindhoven, Leiden, Tilburg
2021-12-02
Active, closed
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016Relapsed/Refractory Small Cell Lung Cancer
Amgen
Phase 2
222
Leiden, Rotterdam
2021-12-01
Recruiting
Leiden University Medical Center
Phase 3
316
Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leeuwarden, Leiden, Maastricht
2021-11-11
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2
25
Amsterdam, Eindhoven, Leeuwarden, Leiden, Nijmegen, Rotterdam, Utrecht
2021-11-05
Recruiting
Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
NCT05463757Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma, Gorlin Syndrome
Maastricht University Medical Center
Observational
80
Nijmegen, Maastricht, Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2021-11-01
Active, closed
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
NCT05059262Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse
Deciphera Pharmaceuticals, LLC
Phase 3
123
Leiden
2021-10-14
Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
NCT04889872Aortic Stenosis, Calcific, Aortic Valve Stenosis
Edwards Lifesciences
Not applicable
2,250
Amsterdam, Leiden, Rotterdam
2021-10-12
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
Inhibrx Biosciences, Inc
Phase 2
206
Groningen, Leiden
2021-09-23
Active, closed
AstraZeneca
Phase 1/2
212
Groningen, Leiden, Utrecht
2021-09-14
Active, closed
Immunome, Inc.
Phase 2/3
198
Amsterdam, Leiden, Rotterdam
2021-09-01
Active, closed
Leiden University Medical Center
Not applicable
120
Nijmegen, Maastricht, Amsterdam, Groningen, Leiden, Rotterdam, Utrecht
2021-08-24
Recruiting
Clinical Validation of BoneMRI in the Spine
NCT06745791Bone Diseases, Image, Medical Device
MRIguidance B.V.
Observational
450
Utrecht, Amsterdam, Leiden, Rotterdam, Tilburg
2021-08-20
Recruiting
Miltenyi Biomedicine GmbH
Phase 2
213
Amsterdam, Groningen, Leiden, Rotterdam
2021-08-18
Active, closed
Merck Sharp & Dohme LLC
Phase 2
730
Maastricht, Leiden, Utrecht
2021-08-18
Active, closed
Boston Scientific Corporation
Phase 4
544
Leiden, Nieuwegein, Utrecht
2021-08-02
Recruiting
Novartis Pharmaceuticals
Phase 3
98
Leiden, Nijmegen
2021-07-28
Active, closed
The Netherlands Cancer Institute
Phase 3
423
Amsterdam, Breda, Eindhoven, Enschede, Groningen, Heerlen, Leeuwarden, Leiden
2021-07-08
Recruiting
Boehringer Ingelheim
Phase 1
554
Amsterdam, Leiden
2021-07-02
Active, closed
The Netherlands Cancer Institute
Not applicable
168
Groningen, Leiden, Nijmegen, Rotterdam
2021-06-25
Recruiting
Penumbra Inc.
Observational
1,500
Leiden
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Nijmegen, Maastricht, 's-Hertogenbosch, Tilburg, Amsterdam, Leiden, Leidschendam, Schiedam
2021-06-18
Active, closed
Leiden Thrombosis Recurrence Risk Prevention
NCT06087952Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism, Deep Vein Thrombosis
Leiden University Medical Center
Not applicable
608
Leiden, Amsterdam, Assen, Beverwijk, Breda, Deventer, Drachten, Ede
2021-06-18
Active, closed
Daiichi Sankyo
Phase 2
155
Leiden, Maastricht
2021-06-03
Recruiting
Universitaire Ziekenhuizen KU Leuven
Not applicable
182
Leiden
2021-04-28
Active, closed
NS Pharma, Inc.
Phase 3
74
Leiden, Nijmegen
2021-04-13
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Alkmaar, Amsterdam, Leiden, Rotterdam
2021-04-01
Recruiting
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
NCT04786262Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia
Vertex Pharmaceuticals Incorporated
Phase 3
57
Leiden
2021-03-29
Recruiting
Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas
NCT04832620Bone Neoplasm of Vertebral Column, Chordoma, Chondrosarcoma, Magnetic Resonance Imaging
Leiden University Medical Center
Observational
40
Delft, Leiden
2021-02-02
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT04031677Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
250
Amsterdam, Leiden, Nijmegen
2021-01-20
Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
NCT05076942Vulvar Cancer, Sentinel Lymph Node, Lymph Node Metastases
University Medical Center Groningen
Phase 2
157
Eindhoven, Groningen, Leiden, Nijmegen, Rotterdam, Utrecht
2021-01-01
Active, closed
Neurocrine Biosciences
Phase 3
182
Leiden
2020-12-16
Recruiting
Catharina Ziekenhuis Eindhoven
Phase 3
364
Amsterdam, Eindhoven, Groningen, Leiden, Leidschendam, Maastricht, Rotterdam
2020-11-13
Active, closed
The ENCIRCLE Trial
NCT04153292Mitral Regurgitation, Mitral Valve Insufficiency
Edwards Lifesciences
Not applicable
786
Leiden, Rotterdam
2020-11-12
Active, closed
Genmab
Phase 1/2
543
Amsterdam, Groningen, Leiden, Maastricht, Rotterdam, Utrecht
2020-11-03
Active, closed
University of Zurich
Not applicable
986
Leiden, Rotterdam
2020-09-30
Recruiting
Leiden University Medical Center
Observational
300
Leiden
2020-08-15
Active, closed
Genentech, Inc.
Phase 1
498
Amsterdam, Leiden, Maastricht, Utrecht
2020-07-29
Recruiting
Doxapram Therapy in Preterm Infants (DOXA Trial)
NCT04430790Apnea of Prematurity, Respiratory Insufficiency
Erasmus Medical Center
Phase 3
396
Nijmegen, Maastricht, Veldhoven, Amsterdam, Zwolle, Leiden, Rotterdam, Groningen
2020-06-15
Recruiting
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
NCT04263038Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases
Drahomir Aujesky
Phase 4
276
Dordrecht, Enschede, Leiden, Rotterdam, The Hague, Zwolle
2020-05-15
Active, closed
Immunocore Ltd
Phase 1/2
410
Amsterdam, Groningen, Leiden
2020-02-25
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Maastricht, Amsterdam, Leiden, Groningen
2020-02-11
Recruiting
Eli Lilly and Company
Phase 2
105
Leiden, Utrecht
2020-01-22
Recruiting
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
NCT04073290Hepatic Encephalopathy, Cirrhosis, Liver, Portal Hypertension, Liver Diseases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 4
238
Amsterdam, Groningen, Leiden, Nijmegen, Rotterdam
2020-01-21
Recruiting
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
NCT04559425Heart Block Complete, Heart Block Second Degree
The Hospital for Sick Children
Observational
350
Leiden
2020-01-01
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Amsterdam, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam
2020-01-01
Active, closed
PHP and Immunotherapy in Metastasized UM
NCT04283890Uveal Melanoma, Metastatic
Leiden University Medical Center
Phase 1/2
83
Leiden
2019-12-04
Recruiting
Medtronic Cardiac Surgery PMCF Registry
NCT04073420Valve Disease, Heart
Medtronic Cardiac Surgery
Observational
2,700
Leiden
2019-12-02
Active, closed
Surveillance AFter Extremity Tumor surgerY
NCT03944798Soft Tissue Sarcoma, Lung Metastases
McMaster University
Not applicable
310
Leiden
2019-11-19
Active, closed
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
NCT04036682Non Small Cell Lung Cancer, EGFR Exon 20 Mutation
Cullinan Therapeutics Inc.
Phase 1/2
284
Amsterdam, Leiden
2019-10-31
Active, closed
Novartis Pharmaceuticals
Phase 1
120
Leiden
2019-10-30
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals
Phase 3
225
Leiden
2019-10-03
Recruiting
Erasmus Medical Center
Phase 2
66
Leiden, Rotterdam, Groningen
2019-09-16
Active, closed
PDC*line Pharma SAS
Phase 1/2
73
's-Hertogenbosch, Amsterdam, Leiden
2019-09-10
Recruiting
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
NCT04832607AdV Infection, EBV Infection, CMV Infection, Stem Cell Transplant Complications
Tobias Feuchtinger
Phase 3
149
Leiden
2019-08-27
Active, closed
RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
NCT03797196Renal Transplant Recipients, Elderly Patients, Immunosuppression
University Medical Center Groningen
Phase 4
374
Amsterdam, Groningen, Leiden, Nijmegen, Rotterdam, Utrecht
2019-07-29
Recruiting
Surgimab
Phase 3
300
Eindhoven, Leiden, Rotterdam
2019-06-17
By invitation
Prospective Registry on Intravascular Lithotripsy
NCT06577038Calcific Coronary Arteriosclerosis
Leiden University Medical Center
Observational
1,000
Amsterdam, Leiden, 's-Hertogenbosch, Arnhem, Leeuwarden, Nijmegen
2019-05-01
Active, closed
Leiden University Medical Center
Observational
500
Leiden
2019-03-05
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Amsterdam, Groningen, Leiden
2019-02-08
By invitation
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
NCT04520347Ventricular Arrhythmia, Ventricular Tachycardia, Premature Ventricular Contraction (PVC), Cardiomyopathy
University of California, Los Angeles
Observational
10,000
Leiden, Rotterdam
2018-12-01
Recruiting
Inhibrx Biosciences, Inc
Phase 1
411
Groningen, Leiden
2018-10-08
Recruiting
The Hospital for Sick Children
Observational
4,100
Nijmegen, Boxmeer, Amsterdam, Leiden, Rotterdam, Groningen, Utrecht
2018-08-24
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
71
Amersfoort, Amsterdam, Enschede, Groningen, Leiden, Maastricht, Nieuwegein, Rotterdam
2018-06-04
Active, closed
JenaValve Technology, Inc.
Not applicable
100
Leiden, Nieuwegein, Rotterdam
2018-04-20
Active, closed
Development of Novel Clinical Endpoints in Intermediate AMD
NCT03349801Age Related Macular Degeneration (AMD)
Frank G. Holz
Observational
718
Leiden, Nijmegen
2018-03-26
Recruiting
Centre for Human Drug Research, Netherlands
Phase 4
30
Leiden
2018-03-20
Recruiting
Leiden University Medical Center
Phase 4
120
Amsterdam, Enschede, Leiden, Rotterdam, The Hague
2018-02-01
Recruiting
Italfarmaco
Phase 2/3
206
Leiden, Nijmegen
2017-10-24
Recruiting
University of Exeter
Observational
300
Leiden
2017-09-19
Active, closed
Potassium Supplementation in CKD
NCT03253172Renal Insufficiency, Chronic, Potassium Depletion, Hypertension, Hyperkalemia
Erasmus Medical Center
Not applicable
532
Amsterdam, Groningen, Leiden, Rotterdam
2017-07-01
Active, closed
Göteborg University
Observational
72
Leiden
2017-05-01
Recruiting
Italian Sarcoma Group
Not applicable
100
Amsterdam, Leiden
2017-03-16
Active, closed
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03069469Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor
Deciphera Pharmaceuticals, LLC
Phase 1/2
120
Leiden
2017-02-16
Active, closed
AbbVie
Phase 3
950
Nijmegen, Amsterdam, Leiden, Rotterdam, Utrecht
2017-01-31
Active, closed
The Netherlands Cancer Institute
Phase 3
174
Enschede, Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
2017-01-25
Recruiting
UMC Utrecht
Observational
500
Amsterdam, Breda, Enschede, Leiden, Maastricht, Utrecht
2016-10
Active, closed
Cardiovascular Research Foundation, New York
Not applicable
178
Utrecht, Leiden, Rotterdam, Zwolle
2016-09
Active, closed
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
NCT03469674Endometrial Cancer Stage I, Endometrial Cancer Stage II
Leiden University Medical Center
Phase 3
550
Amsterdam, Arnhem, Eindhoven, Flushing, Groningen, Leeuwarden, Leiden, Maastricht
2016-06-10
Active, closed
Hoffmann-La Roche
Phase 2
534
Leiden
2015-11-19
Active, closed
AstraZeneca
Phase 3
1,126
Amsterdam, Breda, Enschede, Groningen, Leiden, Maastricht, Nijmegen
2015-11-02
Active, closed
Region Skane
Not applicable
72
Leiden
2015-10
Active, closed
Medtronic
Observational
3,100
Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nieuwegein
2015-07
Active, closed
Exelixis
Phase 4
247
Amsterdam, Leiden, Groningen
2015-02-25
Active, closed
Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers
NCT02321228BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer
University Medical Center Nijmegen
Not applicable
510
Maastricht, Eindhoven, Tilburg, Amsterdam, Leiden, Rotterdam, Groningen, Leeuwarden
2015-01
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Leiden
2014-12-04
Active, closed
Eli Lilly and Company
Phase 3
493
The Hague, Leiden
2014-11-06
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Amsterdam, Leiden
2014-11
Active, closed
PERIGON Pivotal Trial
NCT02088554Aortic Stenosis
Medtronic Cardiac Surgery
Not applicable
1,312
Leiden, Rotterdam
2014-05-12
Active, closed
AstraZeneca
Phase 3
1,837
Amsterdam, Breda, Geleen, Leiden, Maastricht, Rotterdam, Zaandam
2014-04-22
Recruiting
Leiden University Medical Center
Observational
100
Leiden
2014-01-01
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Leiden, Utrecht
2013-04
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Groningen, Leiden, Maastricht
2012-07
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Amsterdam, Doetinchem, Eindhoven, Enschede, Groningen, Hengelo, Leiden, Maastricht
2012-01
Recruiting
Medtronic
Observational
20,000
Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nieuwegein
1983-01
Rows per page Showing 1–386 of 386
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/leiden

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,175 studies in total at the last sync on 13 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 386 of those studies with a site in Leiden.

How many clinical trials are recruiting in Leiden?

230 of the 386 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:17 UTC sync. A further 18 have not yet opened recruitment, 127 are active but closed to new participants, and 11 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Leiden), 386 studies
PhaseStudiesRecruitingShare
Phase 31115628.8%
Observational775419.9%
Not applicable755219.4%
Phase 2482512.4%
Phase 1/223116%
Phase 122125.7%
Phase 417124.4%
Phase 2/31383.4%

Most active sponsors

Lead sponsors with the most studies (Leiden)
Lead sponsorStudiesRecruiting
Leiden University Medical Center7353
Erasmus Medical Center1411
Novartis Pharmaceuticals125
The Netherlands Cancer Institute125
AstraZeneca95
Merck Sharp & Dohme LLC94
argenx72
Genmab71
University Medical Center Groningen75
Bristol-Myers Squibb62
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.